RIGEL PHARMACEUTICALS |
USA |
Gesundheit |
US7665597024 / A40EFY |
RI2 (Frankfurt) / RIGL (NASDAQ) |
FRA:RI2, ETR:RI2, RI2:GR, NASDAQ:RIGL |
- |
https://www.rigel.com/ |
Rigel Pharmaceuticals Inc. is a biotechnology comp..
>Volltext.. |
599.08 Mio. EUR |
558.63 Mio. EUR |
230.33 Mio. EUR |
92 Mio. EUR |
84.09 Mio. EUR |
4.72 EUR |
52.48 Mio. EUR |
45.91 Mio. EUR |
56.59 Mio. EUR |
1.25 |
86.96% |
- |
- |
- |
- |
- |
RIGEL PHARMACEUTICALS, RIGEL PHARMA, RIGEL PHARMACEUTICAL |
03.09.25 |
|